Ibuprofen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Tablet, Capsule, Syrup, and Injection), By Route of Administration (Oral and Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Region and Competition 2018-2028

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

Forecast Period	2024-2028
Market Size (2022)	USD 108.12 Million
CAGR (2023-2028)	4.7%
Fastest Growing Segment	Contract Manufacturing Organizations (CMO)
Largest Market	North America

Market Overview

Global Ibuprofen Market has valued at USD 108.12 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.7% through 2028. Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class and is utilized for the treatment of pain, fever, and inflammation. This encompasses conditions like menstrual cramps, migraines, and rheumatoid arthritis. It is also employed in the treatment of a premature baby with a patent ductus arteriosus. Ibuprofen can be administered orally or intravenously, and its effects are noticeable within an hour. Although generally safe, the consumption of ibuprofen may lead to side effects such as heartburn, rash, and gastrointestinal bleeding. Additionally, it is important to note that ibuprofen can potentially increase the risk of heart attack and exacerbate asthma. Medical professionals typically advise patients to use caution when taking ibuprofen during early pregnancy as it can be hazardous in the later stages. Furthermore, ibuprofen is also utilized in the treatment of conditions such as juvenile idiopathic arthritis, rheumatoid arthritis, and pericarditis.

Key Market Drivers

Growing Prevalence of Chronic Disorders

The increasing incidence and prevalence of chronic diseases, including cardiovascular disease, cancer, arthritis, and others, are continuously driving the demand and consumption of ibuprofen drugs. As more individuals are affected by these conditions, the need for effective pain relief and anti-inflammatory medication grows. This factor is expected to significantly contribute to the projected revenue growth of the global ibuprofen market in the years to come. Furthermore, the rising aging population around the world further amplifies the demand for ibuprofen. As people age, they become more susceptible to chronic conditions and joint-related issues, leading to a greater need for pain management and inflammation reduction. Ibuprofen, with its proven efficacy and widespread availability, plays a crucial role in managing symptoms and improving the quality of life for patients worldwide.

The versatility of ibuprofen extends beyond its pain-relieving properties. It is also commonly used to reduce fever and alleviate menstrual cramps, making it a go-to medication for various conditions. The ease of access to ibuprofen, both over the counter and through prescriptions, ensures that individuals can obtain relief quickly and conveniently. The increasing prevalence of chronic diseases, the aging population, and the diverse applications of ibuprofen contribute to its growing demand and market revenue. As a trusted and effective medication, ibuprofen continues to play a vital role in managing symptoms and enhancing the well-being of patients across the globe.

Expanding Pharmaceutical Production

Pharmaceutical companies worldwide are strategically allocating their resources to enhance production efficiency and intensify research and development endeavors. One such example is ibuprofen, a widely used non-steroidal anti-inflammatory drug that not only exhibits substantial demand but also holds significant profit potential in the market. With its proven effectiveness in relieving pain and reducing inflammation, ibuprofen has become a go-to choice for many individuals seeking relief.

The continuous efforts made by pharmaceutical companies to improve the production and availability of this medication further contribute to meeting the needs of the global population. These companies invest in state-of-the-art manufacturing facilities, advanced technologies, and rigorous quality control measures to ensure the highest standards of safety and efficacy. Moreover, they collaborate with healthcare professionals, researchers, and regulatory authorities to conduct extensive clinical trials and gather comprehensive data on the drug's efficacy and safety profile. Furthermore, pharmaceutical companies are actively exploring new formulations and delivery mechanisms to enhance the drug's effectiveness and patient convenience. From extended-release tablets to topical gels, these innovations aim to provide tailored solutions for different patient populations and medical conditions. Additionally, companies are investing in research and development to identify potential new therapeutic applications of ibuprofen, expanding its utility beyond its traditional uses.

The dedication and strategic resource allocation by pharmaceutical companies have led to the continuous improvement and availability of ibuprofen. With ongoing research, innovation, and collaboration, these companies strive to meet the evolving needs of individuals worldwide, ensuring access to a trusted and effective medication for pain relief and inflammation reduction.

Advanced Technologies in Drug Development

The rapid rise in technological advancements in drug discovery is expected to create immense potential for market growth in the future. With the integration of supercomputing and artificial intelligence, researchers are now able to accurately detect and analyze chemical compounds, revolutionizing the entire drug discovery system. This advanced approach not only enhances effectiveness but also significantly reduces the time required for drug development.

Moreover, the utilization of automation, cutting-edge imaging hardware, and advanced software further accelerates the drug development process. These technologies facilitate faster identification and enhanced screening, enabling pharmaceutical companies to bring new drugs to market more efficiently. As a result, the incorporation of these advanced technologies in drug development is projected to drive the growth of the ibuprofen market during the forecast period.

In addition to the aforementioned advancements, precision medicine and personalized drug development are also playing a pivotal role in shaping the future of the pharmaceutical industry. By tailoring treatments to individual patients based on their genetic makeup, lifestyle, and other factors, precision medicine aims to optimize therapeutic outcomes and minimize adverse effects. This individualized approach holds great promise for the development of targeted therapies and the improvement of patient outcomes. The integration of big data analytics and machine learning algorithms in drug discovery processes is unlocking new possibilities for identifying novel drug targets and predicting drug responses. By analyzing vast amounts of data, including genomic data, clinical records, and drug interactions, researchers can uncover valuable insights and patterns that can guide the development of innovative therapies. The convergence of various technological advancements and innovative approaches in drug discovery and development is revolutionizing the pharmaceutical industry. From supercomputing and artificial intelligence to precision medicine and big data analytics, these advancements are paving the way for more efficient and effective drug development, ultimately benefiting patients worldwide.

Increased In Healthcare Spending

The anticipated rise in healthcare spending is expected to have a direct and substantial impact on the demand for medications like ibuprofen. Healthcare spending is influenced by various factors, including an aging population, increased prevalence of chronic diseases, and advancements in medical treatments. As these factors drive up healthcare expenditure, the demand for cost-effective and widely used medications like ibuprofen is poised to grow.

The expected increase in healthcare spending due to demographic shifts and medical advancements is set to drive up the demand for ibuprofen. As a cost-effective and versatile pain relief medication, ibuprofen is well-positioned to play a pivotal role in addressing the evolving healthcare needs of a growing and aging population.

Download Free Sample Report

Key Market Challenges

Rising Production Costs

The escalation of production costs within the pharmaceutical industry is anticipated to have a dampening effect on the demand for ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID). Several factors contribute to the rising production costs, which can subsequently affect the availability and affordability of ibuprofen for both consumers and healthcare systems. One of the primary contributors to increased production costs is the stringent regulatory environment surrounding pharmaceutical manufacturing. Stricter quality control measures, safety standards, and compliance requirements have necessitated significant investments in research and development, quality assurance, and quality control. These additional expenses are often passed on to consumers, potentially making ibuprofen less attractive as a cost-effective option for pain relief.

Furthermore, the sourcing and production of active pharmaceutical ingredients (APIs) have faced supply chain disruptions and volatility in recent years. The globalization of pharmaceutical manufacturing has made the industry susceptible to geopolitical tensions, natural disasters, and trade restrictions, all of which can lead to fluctuations in raw material costs and supply interruptions. These challenges can result in increased production costs, which can, in turn, impact the price and availability of ibuprofen. Environmental concerns and regulations regarding pharmaceutical waste disposal have prompted manufacturers to invest in more sustainable and eco-friendly production processes. While this is a positive development for the environment, it often comes with added expenses for pharmaceutical companies, which can trickle down to consumers. The rising production costs associated with ibuprofen and other pharmaceuticals may lead to decreased demand, as higher manufacturing expenses can result in elevated prices for consumers and healthcare systems. This can prompt individuals and healthcare providers to seek alternative pain relief options, potentially impacting the overall market for ibuprofen.

Short- And Long-Term Side Effects Of Ibuprofen Drug

The most common type of adverse reaction occurring with Ibuprofen is related to the gastrointestinal tract (GIT). In clinical trials, a significant percentage of patients, ranging from 4% to 16%, reported experiencing one or more gastrointestinal complaints. These adverse effects may include nausea, dyspepsia, diarrhea, constipation, headache, dizziness, rashes, gastrointestinal ulceration/bleeding, salt and fluid retention, and high blood pressure.

Moreover, the long-term use of Ibuprofen has been associated with potential side effects such as heart failure, esophageal ulceration, high blood potassium levels, kidney impairment, liver damage, confusion, and bronchospasm. These effects highlight the importance of cautious usage and monitoring when considering the prolonged use of Ibuprofen. Considering these factors, it is anticipated that the presence of these adverse effects may pose challenges to the revenue growth of the target market.

Key Market Trends

Rising Demand for Pediatric Ibuprofen

Ibuprofen is commonly available over the counter for pain and inflammation relief. The trend of self-medication may continue, driven by consumer preference for easily accessible OTC drugs. Manufacturers may focus on marketing and packaging to cater to this market segment. Ibuprofen is commonly used to reduce fever and relieve pain in children. When used in appropriate dosages, it has a well-established safety profile and is effective in managing conditions such as fever, headaches, and minor injuries. Parents and healthcare providers trust ibuprofen for its safety and efficacy. Children frequently experience common ailments like fever, teething pain, and cold-related discomfort. The availability of pediatric ibuprofen provides parents and caregivers with a reliable option for addressing these health concerns in a manner that is both safe and tailored to a child's needs.

Manufacturers may offer pediatric ibuprofen in forms that are easier for children to take, such as liquid suspensions or chewable tablets. These formulations can make it simpler for parents to administer the medication to their children, enhancing compliance and convenience. Pediatric ibuprofen is formulated with dosages suitable for children's age and weight. This ensures that children receive the appropriate amount of medication for their specific needs, minimizing the risk of over- or under-dosing.

Innovation in Drug Delivery

Pharmaceutical companies may invest in developing new formulations of ibuprofen, such as extended-release or fast-acting variants. These innovations aim to enhance the drug's efficacy, reduce side effects, and improve patient compliance. Extended-release formulations of ibuprofen can provide a steady and prolonged release of the medication over an extended period. This results in sustained pain relief, reducing the need for frequent dosing. Patients experience more consistent pain management, particularly for conditions that require around-the-clock relief, such as chronic pain or arthritis. Modified-release formulations can potentially minimize side effects associated with immediate-release ibuprofen. By releasing the medication gradually, peak plasma concentrations are lower, which may reduce the likelihood of gastrointestinal irritation and other side effects often associated with NSAIDs like ibuprofen.

Pharmaceutical companies can develop formulations of ibuprofen that are tailored to specific patient populations or conditions. For example, fast-acting variants can be designed for acute pain relief, while extended-release versions may be targeted at patients with chronic pain who require long-term therapy. Developing new formulations of existing drugs can extend the patent life of the medication, providing additional protection against generic competition and potential revenue streams for pharmaceutical companies. These innovations expand the therapeutic options available to healthcare providers, allowing them to choose the most appropriate ibuprofen formulation based on a patient's specific needs and medical history.

Segmental Insights

Product Type Insights

The Global Ibuprofen Market is categorized based on product type, including Tablet, Capsule, Syrup, and Injection. Among these, the Tablet segment holds the largest market share in 2022 and is projected to continue dominating the market throughout the forecast period. This is primarily attributed to the wide range of applications of Ibuprofen tablets in the treatment of pain and fever. By reducing inflammation and alleviating pain, this medication is readily available over the counter (OTC) or by prescription from healthcare professionals. It is commonly used to address mild to moderate pain caused by various conditions such as the common cold, flu, arthritis, menstrual cramps, and more. These factors contribute significantly to the growth of the Tablet segment.

Application Insights

The market is segmented into Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, and Others, based on application. During the forecast period, the Rheumatoid Arthritis and Osteoarthritis segment are anticipated to hold the largest revenue share in the Global Ibuprofen Market. This can be attributed to the growing demand for ibuprofen in treating rheumatic musculoskeletal disorders, thanks to its effective analgesic and anti-inflammatory properties. These factors are expected to contribute to the increased demand for ibuprofen in the market.

Download Free Sample Report

Regional Insights

The North American region is expected to exhibit significant dynamism in the future, driven by various factors including a growing geriatric population, increasing healthcare expenditure, and evolving lifestyles with an emphasis on healthy diets. Within this market, the United States is projected to play a major role in terms of revenue contribution. This region has been witnessing notable growth due to heightened awareness of health and wellness among individuals, as well as government initiatives aimed at promoting the pharmaceutical industry in conjunction with a rising geriatric population base. Meanwhile, Mexico is poised to emerge as an appealing destination for global players seeking to outsource their research and development (R&D) activities, owing to its abundant pool of talented workforce and competitive labor costs. Furthermore, Mexico's geographical proximity to the United States presents an advantage for companies with operations on both sides of the border, affording them cost efficiencies compared to their counterparts.

Recent Developments

In August 2021, Alkem Laboratories announced the launch of Ibuprofen and Famotidine tablets in the US market for the treatment of rheumatoid arthritis and osteoarthritis symptoms.
In March 2021, Abbott introduced a new advertising campaign for Brufen Power spray, featuring actor Tiger Shroff. The campaign highlights the advantages of the spray's double-strength formulation, delivered with a precise one-shot spray, ensuring optimal application.
In September 2020, The Danish Medicines Agency published a study contradicting earlier speculation from certain media and social platforms in March 2020. The study confirmed that the use of ibuprofen and other pain-relieving and anti-inflammatory drugs, known as NSAIDs, is not associated with mortality or worsening of symptoms in patients infected with coronavirus.

Key Market Players

Novartis AG
Pfizer Inc.
Abbott Laboratories Inc.
Gilead Sciences Inc.
Merck KGaA
Astellas Pharma Inc.
Glenmark Pharmaceuticals Ltd.
NATCO Pharma Ltd.
Basilea Pharmaceutical AG
Leadiant Biosciences Inc.

By Product Type	By Route of Administration	By Application	By Source	By End User	By Region
Tablet Capsule Syrup Injection	Oral Intravenous	Rheumatoid Arthritis & Osteoarthritis Ankylosing Spondylitis Inflammatory Diseases Dysmenorrhea Others	Contract Manufacturing Organizations (CMO) In-House	Hospitals Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Ibuprofen Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ibuprofen Market, By Product Type:

o Tablet

o Capsule

o Syrup

o Injection

Ibuprofen Market, By Route of Administration:

o Oral

o Intravenous

Ibuprofen Market, By Application:

o Rheumatoid Arthritis & Osteoarthritis

o Ankylosing Spondylitis

o Inflammatory Diseases

o Dysmenorrhea

o Others

Ibuprofen Market, By Source:

o Contract Manufacturing Organizations (CMO)

o In-House

Ibuprofen Market, By End User:

o Hospitals

o Clinics

o Others

Ibuprofen Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia-Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Kuwait

§ Turkey

§ Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ibuprofen Market.

Available Customizations:

Global Ibuprofen market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Ibuprofen Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validations

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ibuprofen Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Tablet, Capsule, Syrup, and Injection)

5.2.2. By Route of Administration (Oral and Intravenous)

5.2.3. By Application (Rheumatoid Arthritis & Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others)

5.2.4. By Source (Contract Manufacturing Organizations (CMO), In-House)

5.2.5. By End User (Hospitals, Clinics, Others)

5.2.6. By Region

5.2.7. By Company (2022)

5.3. Market Map

6. North America Ibuprofen Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Route of Administration

6.2.3. By Application

6.2.4. By Source

6.2.5. By End User

6.2.6. By Country

6.3. North America: Country Analysis

6.3.1. United States Ibuprofen Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Route of Administration

6.3.1.2.3. By Application

6.3.1.2.4. By Source

6.3.1.2.5. By End User

6.3.2. Canada Ibuprofen Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Route of Administration

6.3.2.2.3. By Application

6.3.2.2.4. By Source

6.3.2.2.5. By End User

6.3.3. Mexico Ibuprofen Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Route of Administration

6.3.3.2.3. By Application

6.3.3.2.4. By Source

6.3.3.2.5. By End User

7. Europe Ibuprofen Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Route of Administration

7.2.3. By Application

7.2.4. By Source

7.2.5. By End User

7.2.6. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Ibuprofen Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Route of Administration

7.3.1.2.3. By Application

7.3.1.2.4. By Source

7.3.1.2.5. By End User

7.3.2. United Kingdom Ibuprofen Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Route of Administration

7.3.2.2.3. By Application

7.3.2.2.4. By Source

7.3.2.2.5. By End User

7.3.3. Italy Ibuprofen Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecasty

7.3.3.2.1. By Product Type

7.3.3.2.2. By Route of Administration

7.3.3.2.3. By Application

7.3.3.2.4. By Source

7.3.3.2.5. By End User

7.3.4. France Ibuprofen Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Route of Administration

7.3.4.2.3. By Application

7.3.4.2.4. By Source

7.3.4.2.5. By End User

7.3.5. Spain Ibuprofen Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Route of Administration

7.3.5.2.3. By Application

7.3.5.2.4. By Source

7.3.5.2.5. By End User

8. Asia-Pacific Ibuprofen Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Route of Administration

8.2.3. By Application

8.2.4. By Source

8.2.5. By End User

8.2.6. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Ibuprofen Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Route of Administration

8.3.1.2.3. By Application

8.3.1.2.4. By Source

8.3.1.2.5. By End User

8.3.2. India Ibuprofen Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Route of Administration

8.3.2.2.3. By Application

8.3.2.2.4. By Source

8.3.2.2.5. By End User

8.3.3. Japan Ibuprofen Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Route of Administration

8.3.3.2.3. By Application

8.3.3.2.4. By Source

8.3.3.2.5. By End User

8.3.4. South Korea Ibuprofen Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By Route of Administration

8.3.4.2.3. By Application

8.3.4.2.4. By Source

8.3.4.2.5. By End User

8.3.5. Australia Ibuprofen Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By Route of Administration

8.3.5.2.3. By Application

8.3.5.2.4. By Source

8.3.5.2.5. By End User

9. South America Ibuprofen Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Route of Administration

9.2.3. By Application

9.2.4. By Source

9.2.5. By End User

9.2.6. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Ibuprofen Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Route of Administration

9.3.1.2.3. By Application

9.3.1.2.4. By Source

9.3.1.2.5. By End User

9.3.2. Argentina Ibuprofen Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Route of Administration

9.3.2.2.3. By Application

9.3.2.2.4. By Source

9.3.2.2.5. By End User

9.3.3. Colombia Ibuprofen Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Route of Administration

9.3.3.2.3. By Application

9.3.3.2.4. By Source

9.3.3.2.5. By End User

10. Middle East and Africa Ibuprofen Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By Route of Administration

10.2.3. By Application

10.2.4. By Source

10.2.5. By End User

10.2.6. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Ibuprofen Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By Route of Administration

10.3.1.2.3. By Application

10.3.1.2.4. By Source

10.3.1.2.5. By End User

10.3.2. Saudi Arabia Ibuprofen Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By Route of Administration

10.3.2.2.3. By Application

10.3.2.2.4. By Source

10.3.2.2.5. By End User

10.3.3. UAE Ibuprofen Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By Route of Administration

10.3.3.2.3. By Application

10.3.3.2.4. By Source

10.3.3.2.5. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Ibuprofen Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Service Offerings

15.3. Recent Developments

15.4. Key Personnel

15.5. SWOT Analysis

15.5.1. Novartis AG

15.5.2. Pfizer Inc.

15.5.3. Abbott Laboratories Inc.

15.5.4. Gilead Sciences Inc.

15.5.5. Merck KGaA

15.5.6. Astellas Pharma Inc.

15.5.7. Glenmark Pharmaceuticals Ltd.

15.5.8. NATCO Pharma Ltd.

15.5.9. Basilea Pharmaceutical AG

15.5.10. Leadiant Biosciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions

What was the market size of the Global Ibuprofen Market in 2022?

The market size of the Global Ibuprofen Market was estimated to be USD 108.12 Million in 2022.

Which was the dominant segment by source in the Global Ibuprofen Market in 2022?

Based on source, the segment is categorized into two main categories: contract manufacturing organizations (CMO) and in-house. However, it is projected that the CMO segment will have a dominant position in the market during the forecast period. This can be attributed to various factors such as cost-effectiveness, scalability, and specialized expertise that CMOs bring to the table. Their ability to provide efficient manufacturing solutions and meet the growing demands of the market gives them an edge over in-house manufacturing.

Which is the dominant region in the Global Ibuprofen Market?

Among the regional markets, North America holds the largest revenue share in the Global Ibuprofen Market in 2022 and is projected to maintain its dominance throughout the forecast period. The revenue growth in the North American market can be primarily attributed to factors such as increased public awareness regarding health and wellbeing, a rise in the geriatric population, higher healthcare spending, lifestyle changes, and the significant presence of major market players in the region.

What are the major drivers for the Global Ibuprofen Market?

Rise in pharmaceutical and biopharmaceutical production and rising prevalence of chronic diseases are the major drivers for the Global Ibuprofen Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Ibuprofen Market to Grow with a CAGR of 4.7% through 2028

Sep, 2023

Increase in incidence and prevalence of cancer and rise in demand for anti-inflammatory drugs is expected to drive the Global Ibuprofen Market growth in the forecast period, 2024-2028.